Leap Therapeutics, Inc. (LPTX) Institutional Ownership

Based on Q4 2024 13F filings, institutional ownership of Leap Therapeutics, Inc. stands at 0.6%, held across 1 reporting institutions.

BIT Capital GmbH is the largest reported institutional holder of LPTX, with approximately 540,000 shares worth $0.00B as of Q4 2024.

No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of LPTX.

Our composite Smart Money Score for LPTX is 42 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.

1 institutions opened new positions in LPTX during Q4 2024, while 0 fully exited. 0 added to existing positions and 0 trimmed.

LPTX institutional ownership fell by 176.31 percentage points quarter-over-quarter, with a net change of +1 holders.

The top 10 institutions account for 100.0% of all reported 13F value in LPTX, and the top 25 account for 100.0%.

All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.